Stefanos Theoharis

Stefanos Theoharis currently works at OneChain Immunotherapeutics SL, as Chief Executive Officer from 2024.
Dr. Theoharis also formerly worked at The London Technology Network, as Consultant, Isarna Therapeutics GmbH, as Head-Business Development from 2011 to 2013, and Bone Therapeutics SA, as Chief Business Officer.
Dr. Theoharis received his graduate degree and doctorate degree from Imperial College London and undergraduate degree from Royal Holloway University of London.